Anti-Allergic Drugs Market Size and Growth Opportunities and Forecast till 2026 - 2035
Anti-Allergic Drugs Market Size, Share & Trends Report, 2026–2035
LAST UPDATED: OCTOBER 2026
The global Anti-Allergic Drugs Market size was valued at USD 34,131.0 million in 2025 and is projected to reach USD 65,896.5 million by 2035, growing at a CAGR of 6.8% from 2026 to 2035. Growth is driven by the rising prevalence of allergic rhinitis, asthma, food and skin allergies, longer pollen seasons linked to climate change, wider use of biologics for severe allergic disease, new needle-free epinephrine options, allergen immunotherapy tablets and drops, and easy access to over-the-counter antihistamines.
Anti-allergic drugs are medicines used to prevent and treat allergic reactions and allergic diseases. They include antihistamines, corticosteroids (nasal, inhaled, topical and oral), decongestants, leukotriene modifiers, mast cell stabilizers, epinephrine for anaphylaxis, biologics such as anti-IgE and anti-IL-4/IL-13 antibodies, and allergen immunotherapy given as injections, tablets or drops. They treat food, skin, drug, indoor and outdoor, latex, insect and other allergies, and are dispensed through hospitals, clinics, ambulatory clinics and retail and online pharmacies.
Anti-Allergic Drugs Market Key Takeaways
Infographic: Anti-Allergic Drugs Market Size and Growth Opportunities and Forecast till 2026 - 2035 | Ameco Research
Anti-Allergic Drugs Market Report Scope
| Report Attribute | Details |
| Anti-Allergic Drugs Market Size in 2025 | USD 34,131.0 Million |
| Anti-Allergic Drugs Market Forecast by 2035 | USD 65,896.5 Million |
| Anti-Allergic Drugs Market CAGR (2026–2035) | 6.8% |
| Analysis Period | 2023–2035 |
| Base Year | 2025 |
| Forecast Period | 2026–2035 |
| Segments Covered | by Type of Allergy, by Medication, by End User, and By Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled | Genentech, Inc. (Roche), Allergan (AbbVie), Allergy Therapeutics, Allergopharma GmbH & Co. KG, Strides Pharma Science Limited, and McNeil Consumer Healthcare (Kenvue) |
| Report Coverage | Market Trends, Drivers, Restraints, Opportunities, Competitive Analysis, Player Profiling, Regulation Analysis |
Anti-Allergic Drugs Market Size Forecast, 2023–2035
Figures for 2025–2035 extend the earlier 2021 baseline of USD 26,234 million at the report's 6.8% CAGR.
| Year | Market Size (USD Million) |
| 2023 (historical) | 29,923.1 |
| 2024 (historical) | 31,957.9 |
| 2025 (base year) | 34,131.0 |
| 2026 (forecast) | 36,451.9 |
| 2027 (forecast) | 38,930.7 |
| 2028 (forecast) | 41,577.9 |
| 2029 (forecast) | 44,405.3 |
| 2030 (forecast) | 47,424.8 |
| 2031 (forecast) | 50,649.7 |
| 2032 (forecast) | 54,093.9 |
| 2033 (forecast) | 57,772.3 |
| 2034 (forecast) | 61,700.8 |
| 2035 (forecast) | 65,896.5 |
Latest Anti-Allergic Drugs Market Trends (2026)
Biologics for allergic disease
Biologics such as anti-IgE and anti-IL-4/IL-13 antibodies are used for severe asthma, chronic urticaria and nasal polyps, and in the U.S. omalizumab was approved in 2024 to reduce reactions from accidental food exposure.
Needle-free epinephrine
A nasal spray epinephrine product approved in the U.S. in 2024 offers an alternative to auto-injectors for emergency treatment of anaphylaxis.
Allergen immunotherapy tablets and drops
Sublingual tablets and drops for grass, ragweed, tree pollen and house dust mite allergies let patients receive immunotherapy at home instead of regular injections.
Longer and stronger pollen seasons
Warmer climates are extending pollen seasons and increasing pollen levels in many regions, raising demand for allergy medicines.
Over-the-counter access
Many antihistamines and nasal steroids are sold without prescription, supporting high self-treatment volumes through pharmacies and online channels.
Food allergy treatment
Oral immunotherapy, biologics and early allergen introduction guidance are changing how food allergies are prevented and managed, especially in children.
Anti-Allergic Drugs Market Dynamics
Growth drivers
- Rising prevalence of allergic rhinitis, asthma and food allergies
- Urbanization, pollution and climate-related pollen changes
- New biologic and immunotherapy treatments
- Wide OTC availability of antihistamines and nasal sprays
- Growing awareness and diagnosis of allergies
Restraints and challenges
- Side effects such as drowsiness and steroid-related risks
- High cost of biologics and immunotherapy
- Generic competition lowering prices
- Underdiagnosis in some regions
Opportunities
Key opportunities include food allergy biologics and immunotherapy, needle-free epinephrine, pediatric formulations, digital allergy management tools, and growing allergy care in Asia Pacific and Latin America.
Anti-Allergic Drugs Market Segment Analysis
By type of allergy
The market is segmented into food allergy, skin allergy, drug allergies, indoor and outdoor allergies, latex allergy, insect allergy and other allergies. Indoor and outdoor allergies such as allergic rhinitis account for the largest share, while food allergy treatment grows quickly with new therapies.
By medication
Medications include antihistamines, epinephrine, corticosteroids, allergen immunotherapy, decongestants and others. Antihistamines hold the largest share, while biologics and allergen immunotherapy are among the fastest-growing segments.
By end user
End users include hospitals, clinics, ambulatory clinics and others such as retail and online pharmacies. Hospitals and clinics handle severe cases and specialist treatment, while pharmacies dominate OTC sales.
Anti-Allergic Drugs Market Regional Analysis
North America is expected to dominate the market, supported by high allergy prevalence, strong use of biologics and epinephrine and wide OTC access.
Europe is a major market with strong allergen immunotherapy use. Asia Pacific is expected to grow fast, driven by urbanization, pollution and rising allergy diagnosis in China, India and Japan.
Latin America and the Middle East & Africa are growing markets with improving access to allergy care.
Anti-Allergic Drugs Market Segmentation
Anti-Allergic Drugs Market Leading Companies
The anti-allergic drugs market includes large pharmaceutical companies with biologics and respiratory drugs, consumer health companies selling OTC antihistamines, and allergen immunotherapy specialists. Companies compete on efficacy, safety, convenience, price and access through prescriptions and OTC channels. Key players profiled in this report include Genentech, Inc. (Roche), Allergan (AbbVie), Allergy Therapeutics, Allergopharma GmbH & Co. KG, Strides Pharma Science Limited, and McNeil Consumer Healthcare (Kenvue).
Genentech, Inc. (Roche)Allergan (AbbVie)Allergy TherapeuticsAllergopharma GmbH & Co. KGStrides Pharma Science LimitedMcNeil Consumer Healthcare (Kenvue)
Key Questions Answered in This Report
- What is the size of the anti-allergic drugs market in 2025, and how large will it be by 2030 and 2035?
- What are the main growth drivers, restraints and opportunities through 2035?
- Which by type of allergy and by medication segments will grow the fastest?
- Which regions and countries offer the largest and fastest-growing opportunities?
- How are biologics, needle-free epinephrine and immunotherapy tablets shaping the anti-allergic drugs market in 2026?
- Who are the leading companies, and what strategies are they using to compete?
Research Methodology
Our estimates draw on interviews with pharmaceutical companies, allergists, health agencies, pharmacies and published clinical literature, supported by secondary data from annual reports, investor materials, trade and customs data, standards bodies and industry journals. Bottom-up estimates of company revenues and top-down estimates of application demand are reconciled through data triangulation, and the model is updated with 2026 developments to forecast the market through 2035.
Related Reports
- Intranasal Drug and Vaccine Delivery Market Report
- ENT Treatment Market Report
- Nasal Drug Delivery Devices Market Report
- Veterinary Dermatology Drugs Market Report
Anti-Allergic Drugs Market: Frequently Asked Questions
How big is the anti-allergic drugs market?
The global anti-allergic drugs market was valued at USD 34,131.0 million in 2025 and is expected to reach USD 65,896.5 million by 2035.
What is the growth rate of the anti-allergic drugs market?
The anti-allergic drugs market is projected to grow at a CAGR of 6.8% from 2026 to 2035.
What will the anti-allergic drugs market be worth in 2030?
The anti-allergic drugs market is projected to reach about USD 47,424.8 million in 2030, growing at a CAGR of 6.8%.
What is driving growth in the anti-allergic drugs market?
Key drivers are rising allergy prevalence, urbanization and pollution, new biologics and immunotherapies, OTC availability and better diagnosis.
What is anti-allergic drugs?
Anti-allergic drugs are medicines such as antihistamines, corticosteroids, epinephrine, biologics and immunotherapy used to prevent and treat allergic reactions.
Which region leads the anti-allergic drugs market?
North America is expected to dominate the market, while Asia Pacific is expected to grow fast.
Which segment holds the largest share of the anti-allergic drugs market?
Antihistamines are the leading medication, indoor and outdoor allergies are the largest allergy type, and biologics and immunotherapy grow fastest.
What are the latest trends in the anti-allergic drugs market?
The main 2026 trends are biologics for allergic disease, needle-free epinephrine, allergen immunotherapy tablets and drops, longer and stronger pollen seasons, over-the-counter access and food allergy treatment.
What are the main challenges in the anti-allergic drugs market?
The main challenges are side effects, the high cost of biologics and immunotherapy, generic price competition and underdiagnosis.
What is allergen immunotherapy?
Allergen immunotherapy gradually exposes the immune system to small, increasing doses of an allergen through injections, tablets or drops to reduce allergic reactions over time.
Who are the key players in the anti-allergic drugs market?
Leading companies include Genentech, Inc. (Roche), Allergan (AbbVie), Allergy Therapeutics, Allergopharma GmbH & Co. KG, Strides Pharma Science Limited, and McNeil Consumer Healthcare (Kenvue).
Related Pharma & Healthcare Market Reports
- Nutrition and Weight Management Market Size and Growth Opportunities and Forecast till 2026 - 2035
- Home Fitness Market Size and Growth Opportunities and Forecast till 2026 - 2035
- ENT Treatment Market Size and Growth Opportunities and Forecast till 2026 - 2035
- Healthcare Powered Air Purifying Respirator Market Size and Growth Opportunities and Forecast till 2026 - 2035